Although the hemoglobin level of 100 g/L has been used for many years as th
e allogeneic red blood cell (RBC) transfusion trigger, current evidence ind
icates that for most patients a more restrictive transfusion strategy is at
least as effective as and possibly superior to a liberal transfusion strat
egy. Moreover, the available data indicate that the use of smaller volumes
of allogeneic RBCs may be associated with decreased risk of morbidity and m
ortality. Thus several recent studies indicate that the use of more restric
tive triggers than 100 g/L does not appear to adversely affect patient outc
omes. Indeed, the majority of recently published RBC transfusion guidelines
recommend a more conservative and cautious approach to allogeneic RBC tran
sfusion practice, primarily to reduce the risk of transfusion-related adver
se effects. However, the available transfusion trigger studies do not provi
de sufficient data to allow the claim that the improved outcomes observed a
re the sole result of the transfusion strategy used. It is possible that th
e results are the consequence of effects yet to be defined clearly. Additio
nal studies will be necessary to determine the effects of RBC storage time
and the presence of allogeneic leukocytes in allogeneic RBC transfusion pra
ctice. Nonetheless, the available data, together with detailed information
about alternatives to blood product transfusions, will enable physicians to
improve outcomes in transfused patients. (C) 2001 Editions scientifiques e
t medicales Elsevier SAS.